Nikolaou Anastasis

Related Filers (5)

Ownership (2)

4
Monday, 11/21/2022
Acrivon Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3/A
Monday, 11/14/2022
Acrivon Therapeutics, Inc.: Initial statement of beneficial ownership of securities
Show More